|
|
|
|
 |
The U.S. Food and Drug Administration today announced the addition of a boxed warning to the label of Regranex Gel 0.01% (becaplermin) to address the increased risk of cancer mortality in patients who use 3 or more tubes of the product.
|
|
|
|
Company manufactures and distributes unapproved and adulterated drugs
|
|
|
|
|
